Isenberg Jason 4

What Happened
Jason Isenberg, a director of Intelligent Bio Solutions, was granted 5,000 restricted shares of common stock on March 18, 2026 under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The Form 4 reports the grant at $0.00 per share (total $0 as reported); the award is time‑based and subject to forfeiture until it vests after 12 months.

Key Details

• Transaction date and type: 2026-03-18 — Grant/Award (code A).
• Shares and price: 5,000 restricted shares @ $0.00 (reported value).
• Vesting/forfeiture: Time‑based vesting after 12 months; shares are forfeitable until vested (Footnote F2).
• Post-reverse-split reporting: All amounts are presented post a 1-for-10 reverse split effective Dec 15, 2025 (Footnote F1).
• Shares owned after transaction: Not specified on the provided Form 4.
• Filing timeliness: Reported on 2026-03-20 for a 2026-03-18 transaction — filed within the standard 2‑business‑day window (not late).
• Plan: Issued under the 2019 Long Term Incentive Plan.

Context
This was a compensation award to a director, not an open‑market purchase or sale. Restricted stock grants are common for board compensation; the $0.00 reporting reflects grant reporting conventions on Form 4 and does not indicate market value.